Sorafenib and ponatinib as effective inhibitors of Fusobacterium nucleatum FtsZ: An in silico and in vitro study.

Drug repurposing is a promising strategy that involves re-evaluating the mechanisms of action of existing therapeutics, unlocking their potential for the treatment of other diseases, and expanding their indications. Fusobacterium nucleatum (F. nuclea…

Preview only. Read the full abstract at the source